Document Detail


Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies.
MedLine Citation:
PMID:  15751817     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In APS, most aPL are autoantibodies to beta2-glycoprotein I and prothrombin, which play a major role in the APS pathogenesis. Nevertheless, antibodies with the same antigen specificity are also found in aPL patients with leprosy, in whom thromboembolic complications are uncommon. The in vivo upregulation of the tissue factor (TF) pathway and the imbalance of cytokines have been proposed as potential mechanisms of thrombosis in the APS. We measured the circulating levels of TF, interleukin 6 (IL-6), IL-6 receptor (sIL-6R), tumor necrosis factor (TNF-alpha) and interferon gamma (IFN-gamma) in 83 patients with autoimmune aPL (42 with and 41 without clinical features of definite primary APS), 48 leprosy patients (33 with aPL) and 48 normal controls. There was a trend (P = 0.06) to higher median sTF in patients with autoimmune aPL (139 pg/mL) compared with leprosy patients (103.5 pg/mL) and controls (123 pg/mL). In addition, the frequency of raised sTF levels (> 187 pg/mL) was significantly higher in the group with autoimmune aPL [22.9% (APS 21.4%, non-APS 24.4%)] but not in leprosy (10.4%) compared with controls (4.2%). Elevated levels of IL-6 and TNF-alpha and a trend to lower IFN-gamma were found in patients with definite APS. Leprosy patients with aPL, however, had increased TNF-alpha and IFN-gamma but normal IL-6 levels. Levels of sIL-6R did not differ between controls and either patients with autoimmune aPL or leprosy. The different cytokine profiles as well as differences in circulating levels of TF might contribute to the high thrombotic risk found in patients with autoimmune aPL but not in leprosy related aPL patients.
Authors:
R R Forastiero; M E Martinuzzo; G F de Larrañaga
Related Documents :
15288417 - Impaired self-perception of the hand in complex regional pain syndrome (crps).
3612267 - C-reactive protein levels in the differential diagnosis of brain abscesses.
18577187 - High-sensitivity c-reactive protein measurements in patients with non-arteritic anterio...
12865067 - Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis.
22653657 - Immunomodulatory therapies delay disease progression in multiple sclerosis.
24032287 - Subtelomeric rearrangements in patients with idiopathic intellectual disabilitiy/ multi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Lupus     Volume:  14     ISSN:  0961-2033     ISO Abbreviation:  Lupus     Publication Date:  2005  
Date Detail:
Created Date:  2005-03-08     Completed Date:  2005-06-21     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9204265     Medline TA:  Lupus     Country:  England    
Other Details:
Languages:  eng     Pagination:  129-36     Citation Subset:  IM    
Affiliation:
Favaloro University, Favaloro Foundation, Buenos Aires, Argentina. forastiero@favaloro.edu.ar
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Antiphospholipid / blood
Antiphospholipid Syndrome / blood*
Child
Female
Humans
Interferon-gamma / blood*
Interleukin-6 / blood*
Leprosy / blood*
Male
Middle Aged
Receptors, Interleukin-6 / blood
Thromboplastin / metabolism*
Tumor Necrosis Factor-alpha / metabolism*
Chemical
Reg. No./Substance:
0/Antibodies, Antiphospholipid; 0/Interleukin-6; 0/Receptors, Interleukin-6; 0/Tumor Necrosis Factor-alpha; 82115-62-6/Interferon-gamma; 9035-58-9/Thromboplastin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome:...
Next Document:  Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary repo...